Overview
- 8 inspections across 6 sites are on record.
- 19 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2010-05-13.
At a glance
Inspections
8
Sites
6
Observations
19
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ortho-Clinical Diagnostics, Inc. | 13 May 2010 | On file | |
| AstraZeneca Pharmaceuticals LP | 7 Dec 2009 | View 483 → | |
| AstraZeneca Pharmaceuticals LP | 9 Oct 2009 | On file | |
| Lonza Walkersville, Inc. | 10 Oct 2008 | View 483 → | |
| ID Biomedical | 22 May 2008 | On file |
Sites inspected
Ortho-Clinical Diagnostics, Inc.Raritan, United States1 insp.
AstraZeneca Pharmaceuticals LPPhiladelphia, United States2 insp.
Lonza Walkersville, Inc.Walkersville, United States1 insp.
ID BiomedicalLaval, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Joan A Loreng3 shared
Martha T Olone2 shared
Paula A Trost1 shared
Edward Patten1 shared
Susan S Yu1 shared
Jacqueline M Diaz Albert1 shared
Full investigator report
Get the verbatim findings behind Ann M Montemurro's 19 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site